These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS? Kang BJ, Cho MJ, Oh JT, Lee Y, Chae BJ, Ko J. Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201 [Abstract] [Full Text] [Related]
12. Clozapine-induced transient white blood count disorders. Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW. J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519 [Abstract] [Full Text] [Related]
14. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection]. Alfaro J, Berdichevsky E, Conte G, Tellez C. Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216 [Abstract] [Full Text] [Related]
16. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital. Maskasame S, Krisanaprakornkit T, Khiewyoo J. J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439 [Abstract] [Full Text] [Related]
19. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy. Cohen D, Bogers JP, van Dijk D, Bakker B, Schulte PF. J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648 [Abstract] [Full Text] [Related]
20. Cost-effectiveness of clozapine monitoring after the first 6 months. Zhang M, Owen RR, Pope SK, Smith GR. Arch Gen Psychiatry; 1996 Oct; 53(10):954-8. PubMed ID: 8857873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]